Aug 21 |
Organon and Lilly expand deal for migraine treatment to new markets
|
Aug 21 |
Zacks Investment Ideas feature highlights: Viking Therapeutics, McDonalds, Starbucks, Novo Nordisk and Eli Lilly
|
Aug 20 |
S&P 500 Gains and Losses Today: Palo Alto Networks Surges After Earnings Beat
|
Aug 20 |
These Two Stocks Plunged After Eli Lilly Drug Study Showed Diabetes Promise
|
Aug 20 |
GLP-1 use cases are growing: What it means for pharma stocks
|
Aug 20 |
Eli Lilly: Tirzepatide's Winning Streak Continues
|
Aug 20 |
Eli Lilly to examine weight loss med Zepbound for immune disorders -- report
|
Aug 20 |
Eli Lilly Says Tirzepatide 'Significantly' Decreases Diabetes Progression Risk
|
Aug 20 |
Boeing Weighs On Dow Jones; This Stock Falls After Warren Buffett Unloads Shares (Live Coverage)
|
Aug 20 |
Lilly’s Mounjaro Looks Unstoppable as Trial Wins Pile Up
|